Gwangju Institute of Science and Technology
- Academic, tech transfer
We are searching for out-licensing opportunities for following technologies: 1)Cancer Immunotherapy Based on TCR Avidity , 2)Novel Therapeutic for Overactive Bladder, 3)Novel Therapeutic for skeletal muscle wasting,4)Antimicrobial peptoids
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}